BRAINSTORM CELL THERAPEUTICS (BCLI)
US10501E2019 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -17.19M | -24.28M | -24.46M | -31.81M | -23.25M | |||
| Depreciation Amortization | 265.00K | 290.00K | 260.00K | 220.00K | 160.00K | |||
| Change In Working Capital | -496.00K | 2.99M | -3.43M | -6.32M | 10.87M | |||
| Other non cash items | -3.04M | 1.68M | 1.37M | 2.72M | 970.00K | |||
| OPERATING CASH FLOW | -20.46M | -19.32M | -26.27M | -35.19M | -11.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -18.00K | -30.00K | -330.00K | -380.00K | -470.00K | |||
| Other Investing Activity | 2.21M | 1.03M | 650.00K | -4.07M | 6.09M | |||
| INVESTING CASH FLOW | 2.19M | 1.00M | 320.00K | -4.45M | 5.62M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 18.98M | 240.00K | 6.97M | 76.94M | 5.23M | |||
| FINANCING CASH FLOW | 18.98M | 240.00K | 6.97M | 76.94M | 5.23M | |||
| CHANGE IN CASH | 713.00K | -18.08M | -18.98M | 37.30M | -400.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.46M | -19.32M | -26.27M | -35.19M | -11.25M | |||
| Capital Expenditure | -18.00K | -30.00K | -330.00K | -380.00K | -470.00K | |||
| FREE CASH FLOW | -20.48M | -19.35M | -26.60M | -35.57M | -11.72M | |||
All data in USD